Facebook Pixel Code
About Sickkids
About SickKids

Victor Blanchette, MD, MA, MB, MRCS, LRCP, DCH, MRCP, FRCP(C), FRCP

The Hospital for Sick Children
McCaig Magee Medical Director, SickKids-Caribbean Initiative
Centre for Global Child Health

Promotions Comittee Member

Cluster Management Team

Education Committee

Scientific Review Board

Research Institute
Senior Associate Scientist Emeritus
Child Health Evaluative Sciences

University of Toronto

Chair Positions

The Hospital for Sick Children
SickKids-Caribbean Initiative

The Hospital for Sick Children
Paediatric Haematology/Oncology
Women's Auxilliary Millennium Chair

Other Positions

Association of Haemophilia Clinic Directors of Canada
Factor Prophylaxis Subcommittee

Canadian Children's Platelet Study Group

The Hospital for Sick Children
Bayer International Haemophilia Advisory Board

The Hospital for Sick Children
Comprehensive Care Hemophilia Program
Medical Director

The Hospital for Sick Children
Paediatric Hemostasis Program
Medical Director

The Hospital for Sick Children
Research Advisory Committee

Camp Trillium
Board of Directors

Canadian Haemophilia Society
Medical and Scientific Advisory Committee

Canadian Red Cross Society Blood Services
Medical and Scientific Advisory Committee, Toronto Centre

Children's Oncology Group
Principal Investigator

Ontario Thalassemia Foundation
Medical Advisory Board

Paediatric Oncology Group of Ontario (POGO)
Board of Directors

Toronto Platelet Immunology Research Group

Phone: 416-813-5852
Fax: 416-813-5327
Email: victor.blanchette@sickkids.ca

Brief Biography

Dr. Victor Blanchette is the McCaig Magee Medical Director and Co-Chair for the SickKids-Caribbean Initiative: Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders. Born in Barbados, Dr. Blanchette is a passionate SCI advocate and leader. In addition to his role as SCI Medical Director, Dr. Blanchette is co-lead for the SCI Clinical CareWorking Group.

Dr. Victor Blanchette is a staff physician in the Division of Haematology/Oncology at the Hospital for Sick Children and Professor of Paediatrics at the University of Toronto. Dr. Blanchette serves as Medical Director of the Paediatric Thrombosis and Haemostasis Program in the Division of Haematology/Oncology . He is a Senior Associate Scientist in the Research Institute and a Clinician Investigator in the Department of Paediatrics.

Dr. Blanchette received his medical training at the University of Cambridge and St. Bartholomew's Hospital in the United Kingdom. His post-graduate medical training included a paediatric residency at Johns Hopkins Hospital in the USA and a fellowship in paediatric haematology/oncology at McMaster University Medical Centre in Canada. Dr. Blanchette's research interest is in the area of the congenital and acquired bleeding disorders of children. He is Chairman of the Factor Prophylaxis Subcommittee of the Association of the Hemophilia Clinic Directors of Canada (AHCDC). Dr. Blanchette is Chair of the Canadian Paediatric Thrombosis and Hemostasis Network and a founding member of an Intercontinental Immune Thrombocytopenic Purpura (ITP) Study Group. In 2002, Dr. Blanchette was appointed as the Inaugural Holder of the Women’s Auxillary Millenium Chair in Paediatric Haematology/Oncology. Dr. Blanchette is Principal Investigator for the Hospital for Sick Children in the Children's Oncology Group (COG) and he is Co-Chair of the recently formed Council of Canadian Paediatric Haematology/Oncology Directors Group. Dr. Blanchette is a member of the Boards of the Paediatric Oncology Group of Ontario (POGO), Camp Oochigeas, Camp Trillium and Candlelighters Canada. Dr. Blanchette is an elected fellow of the Royal College of Physicians and Surgeons of the United Kingdom.

Academic Background

Paediatric Haematology

McMaster University Medical Centre, 1977-07-01 - 1979-07-01

Research Interests

  • Clinical and Basic Science Studies of the Immune Thrombocytopenias of Childhood;
  • Studies in Children with Haemophilia A and B and Other Inherited Bleeding Disorders;
  • Development of Paediatric Transfusion Medicine Guideline


  • Inaugural Holder
    Women’s Auxillary Millenium Chair in Paediatric Haematology/Oncology
    Hospital for Sick Children
    Toronto, Ontario
  • Elected Fellow, Royal College of Physicians, United Kingdom. 1990


Carcao MD, Blanchette VS, Stephens D, He L, Wakefield CD, Butchart S, Christie DJ, Rand ML: Assessment of thrombocytopenic disorders using the platelet function analyzer (PFA-100). British Journal of Haematology 2002; 117(4): 947-951.

Berman J, Young NL, Carcao MD, Blanchette VS, Ipp M: Hospitalization of children with acute idiopathic thrombocytopenic purpura: Is it necessary? Pediatrics and Child Health 2002.

Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA: Fc-gamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. British Journal of Haematology 2002.

Revel-Vilk S, Blanchette VS, Sparling C, Stain A.M., Carcao MD: DDAVP challenge tests in boys with mild/moderate haemophilia A. British Journal of Haematology 2001.